Comparative Efficacy of Extracts from Lycium Barbarum Bark and Fruit on Estrogen Receptor Positive Human Mammary Carcinoma MCF-7 Cells

REFERENCES

• American Cancer Society . 2012 . Facts & Figures 2012. , Atlanta : American Cancer Society .
   Google Scholar
• Sorlie , T , Perou , C M , Tibshirany , R , Aas , T Geisler , S . 2001 . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications . Proc. Natl. Acad. Sci. USA. , 98 : 10869 – 10874 .
   PubMed Web of Science ®Google Scholar
• Perou , C M , Sorlie , T , Eisen , M B , Johnson , H Geisler , S . 2000 . Molecular portraits of human breast tumors . Nature , 406 : 747 – 752 .
   PubMed Web of Science ®Google Scholar
• Dinh , P , Satiriou , C and Piccart , MJ . 2007 . The evaluation of treatment strategies: Aiming at the target . Breast , 16 (Suppl. 2) : S10 – S16 .
   PubMed Web of Science ®Google Scholar
• Molassiotis , A , Scott , J A , Kearney , A and Kearney , N . 2006 . Complementary and alternative use in breast cancer patients in Europe . Support Care Cancer , 14 : 206 – 267 .
   Web of Science ®Google Scholar
• Rock , E and De Michelle , A . 2003 . Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors . J Nutr , 133 : S3785 – S3793 .
   PubMed Web of Science ®Google Scholar
• Hyler , L K , Chin , S and Chui , B K . 2006 . The use of complementary and alternative medicines among patients with locally advanced breast cancer: a descriptive study . BMC Cancer , 6 : 39 – 46 .
   PubMedGoogle Scholar
• Tindle , H A , Davis , R B , Phillips , R L and Eisenberg , D M . 2005 . Trends in the use of complementary and alternative medicines by US adults: 1997–2002 . tern Ther Health Med , 11 : 42 – 49 .
   PubMed Web of Science ®Google Scholar
• Gau , L , Hua Zhang , S , Liang Yang , X and Bi Xu , H . 2004 . Immuno-modulation and anti-tumor activity by a polysaccharide protein complex from Lycium barbarum . Int J Immunopharmacol , 4 : 563 – 569 .
   PubMed Web of Science ®Google Scholar
• Zhou , S-F . 2007 . Chinese herbal medicines for toxicity reduction in cancer chemotherapy . Aust J Acupunct Chinese Med , 2 : 30 – 31 .
   Google Scholar
• Lippman , M E , Osborne , C K , Knazeck , R and Young , N . 1977 . In vitro model systems for the study of hormone dependent human breast cancer . N Engl J Med , 296 : 154 – 159 .
   PubMed Web of Science ®Google Scholar
• Li , G , Sepkovic , D W , Bradlow , H L , Telang , N T and Wong , G YC . 2009 . Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism . Nutrition and Cancer , 61 : 408 – 414 .
   PubMed Web of Science ®Google Scholar
• Mukherjee , B , Telang , N T and Wong , G YC . 2009 . Growth inhibition of estrogen receptor positive human breast cancer cells by Taheebo from the inner bark of Tabebuia avellande tree . Int J Mol Med , 24 : 253 – 260 .
   PubMed Web of Science ®Google Scholar
• Telang , N T , Sepkovic , D W , Bradlow , H L and Wong , G YC . 2010 . Chinese herb Fructus cornii exhibits preventive efficacy in a cell culture model for hormone responsive breast cancer . Cancer Res , 70 : S152 – S153 .
   Web of Science ®Google Scholar
• Telang , N , Li , G , Sepkovic , D W , Bradlow , H L and Wong , G YC . 2011 . Comparative preventive efficacy of aqueous extracts from Lycium barbarum bark and fruit on estrogen receptor positive human mammary carcinoma MCF-7 cells . Cancer Res , 71 : 379S
   Web of Science ®Google Scholar
• Telang , N T , Li , G , Sepkovic , D W , Bradlow , H L and Wong , G YC . 2012 . Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor positive clinical breast cancer . Mol Med Rep , 5 : 22 – 28 .
   PubMed Web of Science ®Google Scholar
• Suto , A , Bradlow , H L , Kubota , T , Kitajima , H Wong , G Y . 1993 . Alteration in proliferative and endocrine responsiveness of human mammary carcinoma cells by prototype tumor suppressing agents . Steroids , 58 : 212 – 219 .
   Web of Science ®Google Scholar
• Telang , N , Li , G , Katdare , M , Sepkovic , D W Bradlow , H L . 2012 . Comparative preventive efficacy of select Chinese herbs in breast carcinoma derived isogenic cells with modulated estrogen receptor functions . Cancer Res , 72 : 190S
   Web of Science ®Google Scholar
• Sepkovic , D W , Bradlow , H L , Michnovicz , J , Murtezani , S Levy , I . 1994 . Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen or ß-napthaflavone: a comparison of stable isotope dilution, gas chromatography-mass spectrophotometry and radiometric methods . Steroids , 59 : 318 – 323 .
   PubMed Web of Science ®Google Scholar
• Dehnin , L , Reiffsteck , A and Scholler , R . 1980 . Simple methods for the synthesis of twenty, different highly enriched deuterium labeled steroids suitable as internal standards for isotope dilution mass spectrophotometry . Biochem Mass Spectrometry , 7 : 493 – 499 .
   Google Scholar
• Raju , U , Sepkovic , D W , Dixon , J M , Bradlow , H L and Levitz , M . 2000 . Estrone and estradiol metabolism in vivo in human breast cysts . Steroids , 65 : 883 – 888 .
   PubMed Web of Science ®Google Scholar
• Lippman , M E . 1983 . Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equals three? . Breast Cancer Res Treat , 3 : 117 – 127 .
   PubMed Web of Science ®Google Scholar
• Early Breast Trialist's Group . 2005 . Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 years survival: an overview of the randomized trials . Lancet , 365 : 1687 – 1717 .
   PubMed Web of Science ®Google Scholar
• Jordan , V C . 2002 . Historical perspective on hormonal therapy of advanced breast cancer . Clin Ther , 24 : A3 – A16 .
   PubMed Web of Science ®Google Scholar
• Schneider , J , Kinne , D , Frachia , A , Pierce , V Anderson , K E . 1982 . Abnormal oxidative metabolism of 17ß-estradiol in women with breast cancer . Proc Natl Acad Sci USA , 79 : 3047 – 3051 .
   PubMed Web of Science ®Google Scholar
• Fishman , J , Schneider , J , Herschkopf , R J and Bradlow , H L . 1984 . Increased estrogen 16α-hydroxylase activity in women with breast and endometrial cancer . J Steroid Biochem Mol Biol , 20 : 1077 – 1081 .
   Web of Science ®Google Scholar
• Yager , J D and Davidson , N E . 2006 . Estrogen carcinogenesis in breast cancer . N Engl J Med , 354 : 270 – 282 .
   PubMed Web of Science ®Google Scholar
• Fishman , J , Osborne , M P and Telang , N T . 1995 . The role of estrogens in mammary carcinogenesis . Ann NY Acad Sci , 768 : 91 – 100 .
   PubMed Web of Science ®Google Scholar
• Schneider , J , Huh , M M , Bradlow , H L and Fishman , J . 1984 . Anti-estrogen action of 2-hydroxyestrone on MCF-7 human breast carcinoma cells . J Biol Chem , 259 : 4840 – 4845 .
   PubMed Web of Science ®Google Scholar
• Lottering , M L , Haag , M and Segers , J C . 1992 . Effects of 17ß-estradiol metabolites on cell cycle events in MCF-7 cells . Cancer Res , 52 : 5926 – 5932 .
   PubMed Web of Science ®Google Scholar
• Telang , N T , Suto , A , Wong , G Y , Osborne , M P and Bradlow , H L . 1992 . Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells . J Natl Cancer Inst , 84 : 634 – 638 .
   PubMed Web of Science ®Google Scholar
• Suto , A , Telang , N T , Tanino , H , Takeshita , T Ohmiya , H . 1999 . In vitro and in vivo modulation of growth regulation in the human breast cancer cell line MCF-7 by estradiol metabolites . Breast Cancer , 6 : 87 – 92 .
   PubMedGoogle Scholar